Lomazzi Chiara, Bissacco Daniele, Logan Meryl S, Grassi Viviana, Piffaretti Gabriele, Trimarchi Santi, Bush Ruth L
Unit of Vascular Surgery, IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
Central Texas VA Healthcare System, Temple, TX, USA.
J Cardiovasc Surg (Torino). 2021 Oct;62(5):427-434. doi: 10.23736/S0021-9509.21.11908-1. Epub 2021 May 20.
Target vein recanalization is defined as the postoperative detection of blood flow in a venous segment previously ablated. It can be occurred after thermal-tumescent procedures, as radiofrequency (RFA) and endovenous laser (EVLA) ablation techniques. Despite several papers described and analyzed incidence and consequences of recanalization, limited data are published on risk factors for this condition. The aim of this general review is to investigate clinical and instrumental risk factors for great and small saphenous veins recanalization after RFA, indicating their impact in the follow-up period.
Articles were obtained through a detailed search of the scientific journal databases (PubMed, Scopus, Web of Science) for those published between January 1, 2011 to December 31, 2020. The term "radiofrequency venous ablation" was combined with "risk factors", "recanalization" and "recurrence", to obtain the first article cluster.
Risk factors analysis for saphenous vein recanalization after ablation is not a well-studied problem. Although several studies have analyzed recanalization patterns and anatomical causes of ablation failure, few and disaggregate data are available regarding clinical preoperative risk factors. BMI and saphenous trunk diameter seem to be the only two recognized characteristics that may affect short and long-term recanalization rate, though CVI status, sex, target vein treatment length and others factors may be taken into account.
Physicians should consider risk factors for recanalization in patient selection and treatment recommendations, but also recognize that not all "ablation failures" are of clinical relevance.
目标静脉再通被定义为在先前已消融的静脉段术后检测到血流。它可能发生在热肿胀手术之后,如射频消融(RFA)和腔内激光消融(EVLA)技术。尽管有几篇论文描述并分析了再通的发生率及后果,但关于这种情况的危险因素的公开数据有限。本综述的目的是研究RFA术后大隐静脉和小隐静脉再通的临床及器械危险因素,并指出它们在随访期的影响。
通过详细检索科学期刊数据库(PubMed、Scopus、Web of Science)获取2011年1月1日至2020年12月31日期间发表的文章。将“射频静脉消融”与“危险因素”“再通”和“复发”相结合,以获得第一组文章。
消融术后隐静脉再通的危险因素分析并非一个研究充分的问题。尽管有几项研究分析了再通模式及消融失败的解剖学原因,但关于临床术前危险因素的数据很少且不完整。BMI和隐静脉主干直径似乎是仅有的两个已确认的可能影响短期和长期再通率的特征,不过也可考虑CVI状态、性别、目标静脉治疗长度及其他因素。
医生在患者选择和治疗建议中应考虑再通的危险因素,但也要认识到并非所有“消融失败”都具有临床相关性。